ReNetX Bio
About:
ReNetX Bio is a technology platform help to restore function in patients who are suffering from spinal cord injuries, stroke and glaucoma.
Website: http://www.renetx.com/
Top Investors: Connecticut Innovations, Spring Mountain Capital, Wings for Life
Description:
ReNetX Bio first-in-class therapeutics to treat injury and damage to the central nervous system (CNS) in conditions such as spinal cord injury (SCI)and glaucoma.
Total Funding Amount:
$9.8M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
New Haven, Connecticut, United States
Founded Date:
2010-01-01
Contact Email:
info(AT)renetx.com
Founders:
Erika Smith, George Maynard
Number of Employees:
11-50
Last Funding Date:
2020-09-28
IPO Status:
Private
Industries:
© 2025 bioDAO.ai